technetium-tc-99m-exametazime and 1-2-distearoyllecithin

technetium-tc-99m-exametazime has been researched along with 1-2-distearoyllecithin* in 2 studies

Other Studies

2 other study(ies) available for technetium-tc-99m-exametazime and 1-2-distearoyllecithin

ArticleYear
Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
    Journal of controlled release : official journal of the Controlled Release Society, 2010, Dec-01, Volume: 148, Issue:2

    In the treatment of peritoneal carcinomatosis, systemic chemotherapy is not quite effective due to the poor penetration of cytotoxic agents into the peritoneal cavity, whereas intraperitoneal administration of chemotherapeutic agents is generally accompanied by quick absorption of the free drug from the peritoneum. Local delivery of drugs with controlled-release delivery systems like liposomes could provide sustained, elevated drug levels and reduce local and systemic toxicity. In order to achieve an ameliorated liposomal formulation that results in higher peritoneal levels of the drug and retention, vesicles composed of different phospholipid compositions (distearoyl [DSPC]; dipalmitoyl [DPPC]; or dimiristoylphosphatidylcholine [DMPC]) and various charges (neutral; negative, containing distearoylphosphatidylglycerol [DSPG]; or positive, containing dioleyloxy trimethylammonium propane [DOTAP]) were prepared at two sizes of 100 and 1000nm. The effect of surface hydrophilicity was also investigated by incorporating PEG into the DSPC-containing neutral and charged liposomes. Liposomes were labeled with (99m)Tc and injected into mouse peritoneum. Mice were then sacrificed at eight different time points, and the percentage of injected radiolabel in the peritoneal cavity and the tissue distribution in terms of the percent of the injected dose/gram of tissue (%ID/g) were obtained. The ratio of the peritoneal AUC to the free label ranged from a minimum of 4.95 for DMPC/CHOL (cholesterol) 100nm vesicles to a maximum of 24.99 for DSPC/CHOL/DOTAP 1000nm (DOTAP 1000) vesicles. These last positively charged vesicles had the greatest peritoneal level; moreover, their level remained constant at approximately 25% of the injected dose from 2 to 48h. Among the conventional (i.e., without PEG) 100nm liposomes, the positively charged vesicles again showed the greatest retention. Incorporation of PEG at this size into the lipid structures augmented the peritoneal level, particularly for negatively charged liposomes. The positively charged PEGylated vesicles (DOTAP/PEG 100) had the second-greatest peritoneal level after DOTAP 1000; however, their peritoneal-to-blood AUC ratio was low (3.05). Overall, among the different liposomal formulations, the positively charged conventional liposomes (100 and 1000nm) provided greater peritoneal levels and retention. DOTAP/PEG100 may also be a more efficient formulation because this formulation can provide a high level of anticancer drug i

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Chemistry, Pharmaceutical; Delayed-Action Preparations; Dimyristoylphosphatidylcholine; Drug Compounding; Fatty Acids, Monounsaturated; Female; Hydrophobic and Hydrophilic Interactions; Injections, Intraperitoneal; Liposomes; Mice; Particle Size; Peritoneal Lavage; Phosphatidylcholines; Phosphatidylglycerols; Phospholipids; Polyethylene Glycols; Quaternary Ammonium Compounds; Radiopharmaceuticals; Surface Properties; Technetium Tc 99m Exametazime; Technology, Pharmaceutical; Tissue Distribution

2010
99mTc-HMPAO-labeled liposomes: an investigation into the effects of some formulation factors on labeling efficiency and in vitro stability.
    Nuclear medicine and biology, 2008, Volume: 35, Issue:3

    Technetium-99m complex of hexamethyl-propylene-amineoxime (HMPAO) is used as an efficient agent to label liposomes. For this, 99mTc-HMPAO is incubated with preformed liposomes that contain glutathione (GSH). Effect of GSH and lipid concentration on labeling efficiency, as well as the effect of lipid composition on in vitro stability of labeled liposomes, was investigated in the present study. d,l-HMPAO was synthesized and kits including d,l-HMPAO and SnCl2.2H2O were optimized at 0.5 mg HMPAO, 5.0 microg SnCl2.2H2O and pH 7, and lyophilized. DSPC/CHOL (molar ratio 2:1) liposomes encapsulating GSH were labeled with 99mTc-HMPAO prepared kits. Increase of GSH concentration in hydration buffer from 5 to 200 mM during liposome preparation resulted in a broad labeling efficiency of liposomes ranging from 4.16% to 69.81%. An initial approximate concentration of 100 mM GSH in the hydration buffer seems to be appropriate for a good labeling efficiency. At the optimum concentration of GSH, change of the total initial lipid concentration from 10 to 70 mM did not produce a remarkable difference in labeling efficiency. Study of the effect of lipid composition on the stability of liposomes showed that all three kinds of labeled liposomes composed of DSPC/CHOL, DPPC/CHOL and DMPC/CHOL (molar ratio 2:1) had good in vitro stability in human plasma at 37 degrees C for 48 h; however, employing DSPC resulted in the most stable ones.

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Chemistry, Pharmaceutical; Cholesterol; Dimyristoylphosphatidylcholine; Drug Compounding; Drug Stability; Glutathione; Humans; Isotope Labeling; Liposomes; Phosphatidylcholines; Plasma; Radiopharmaceuticals; Technetium Tc 99m Exametazime

2008